Conference Reports for NATAP

63rd Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 9-12 2012 Back

First ever successful use of Daclatasvir and GS-7977 (Sofosbuvir) , an IFN-free regimen, in a Liver Transplant recipient with severe recurrent Hepatitis C       Reported by Jules Levin AASLD Nov 2012 Boston   Fontana RJ 1, Hughes EA 2, Bifano M 2, Hindes R 3, Symonds WT 4, Dessislava D 2 1 University of Michigan Medical School, Ann Arbor, MI; 2 Bristol-Myers Squibb, Wallingford, CT; 3 Princeton, NJ, 4 Gilead Sciences, Foster City, CA